Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Italian drugmaker Chiesi to buy KalVista for $1.9 billion

April 29 (Reuters) - Italy's Chiesi has agreed to buy KalVista Pharmaceuticals KALV.O for about $1.9 billion, the company said on Wednesday, as it looks to grow its rare disease drug portfolio.

 (Reporting by Kamal Choudhury in Bengaluru; Editing by Shailesh Kuber)

 ((Kamal.Choudhury@thomsonreuters.com;))

Recent news on Kalvista Pharmaceuticals

See all news